March 15, 2016
Dr Hiroyoshi Nishikawa, head of translational immunology research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center Researchers face the urgent task of developing biomarkers to identify patients suitable for costly immune checkpoint inhibitors as these drugs are expected...read more